000 | 01610 a2200457 4500 | ||
---|---|---|---|
005 | 20250515191029.0 | ||
264 | 0 | _c20091218 | |
008 | 200912s 0 0 eng d | ||
022 | _a1358-863X | ||
024 | 7 |
_a10.1177/1358863X08102001 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLookstein, Robert A | |
245 | 0 | 0 |
_aSirolimus-eluting stent placement for refractory renal artery in-stent restenosis: sustained patency and clinical benefit at 24 months. _h[electronic resource] |
260 |
_bVascular medicine (London, England) _cNov 2009 |
||
300 |
_a361-4 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAngioplasty, Balloon _xadverse effects |
650 | 0 | 4 |
_aCardiovascular Agents _xadministration & dosage |
650 | 0 | 4 | _aDrug-Eluting Stents |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension, Renovascular _xdiagnostic imaging |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMetals |
650 | 0 | 4 | _aProsthesis Design |
650 | 0 | 4 | _aRadiography |
650 | 0 | 4 |
_aRenal Artery Obstruction _xdiagnostic imaging |
650 | 0 | 4 | _aSecondary Prevention |
650 | 0 | 4 |
_aSirolimus _xadministration & dosage |
650 | 0 | 4 | _aStents |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aVascular Patency |
700 | 1 | _aTalenfeld, Adam D | |
700 | 1 | _aRaju, Roman | |
700 | 1 | _aVorchheimer, David A | |
700 | 1 | _aOlin, Jeffrey W | |
700 | 1 | _aMarin, Michael L | |
773 | 0 |
_tVascular medicine (London, England) _gvol. 14 _gno. 4 _gp. 361-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/1358863X08102001 _zAvailable from publisher's website |
999 |
_c19203699 _d19203699 |